Literature DB >> 6741913

Risk factors for pathologically confirmed benign breast disease.

F Parazzini, C La Vecchia, S Franceschi, A Decarli, G Gallus, M Regallo, A Liberati, G Tognoni.   

Abstract

Between November 1981 and March 1983, data were collected to evaluate risk factors for benign breast lesions in a case-control study based on 288 women with histologically proven benign breast disease, admitted for biopsy to the Tumor Institute of Milan, and 285 age-matched controls. Questions were asked about menstrual and reproductive characteristics, marital status, education, history of various diseases, and lifetime use of oral contraceptives and other hormonal treatments. Nulliparity or low parity, late age at first birth, and late menopause were associated with an increased risk of benign breast disease. The elevated risk associated with late age at first birth was not accounted for by parity. Early age at menarche was associated with an increased risk, but the estimate was not statistically significant. The data do not suggest that the use of oral contraceptives or other female hormones (such as estrogen replacement therapy) is related to the risk of benign breast disease. Risk was apparently lower, however, among current and long-term oral contraceptive users. There was no evidence of a trend with reference to body mass index. The present data indicate a substantial agreement between the risk factors for (pathologically confirmed) benign and malignant breast disease, not only directly, by showing a relationship with parity, age at first birth, and age at menopause, but also indirectly, by failing to produce evidence that greater weight or the use of oral contraceptives has a protective effect.

Entities:  

Keywords:  Age Distribution; Age Factors; Anatomy; Anthropometry; Biology; Contraception; Contraceptive Agents, Female; Demographic Factors; Developed Countries; Diseases; Educational Status; Estrogens; Europe; Histology; Hormones; Italy; Mammary Gland Effects; Marital Status; Maternal Age; Mediterranean Countries; Menarche; Menopause; Menstruation; Oral Contraceptives; Parity; Physiology; Population; Population At Risk; Population Characteristics; Population Dynamics; Reproduction; Reproductive Control Agents; Research Methodology; Southern Europe

Mesh:

Substances:

Year:  1984        PMID: 6741913     DOI: 10.1093/oxfordjournals.aje.a113860

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  Risk factors for seromucinous benign ovarian cysts in northern Italy.

Authors:  F Parazzini; S Moroni; E Negri; C La Vecchia; R Mezzopane; P G Crosignani
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

2.  Lifetime physical activity and the incidence of proliferative benign breast disease.

Authors:  Michelle M Jung; Graham A Colditz; Laura C Collins; Stuart J Schnitt; James L Connolly; Rulla M Tamimi
Journal:  Cancer Causes Control       Date:  2011-07-12       Impact factor: 2.506

3.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

4.  A case-control study of breast cancer among Japanese women: with special reference to family history and reproductive and dietary factors.

Authors:  I Kato; S Miura; F Kasumi; T Iwase; H Tashiro; Y Fujita; H Koyama; T Ikeda; K Fujiwara; K Saotome
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

Review 5.  Management of breast fibroadenomas.

Authors:  R Greenberg; Y Skornick; O Kaplan
Journal:  J Gen Intern Med       Date:  1998-09       Impact factor: 5.128

6.  Clinico- pathological profile of patients with breast diseases.

Authors:  Hafiz Muhammad Aslam; Shafaq Saleem; Hiba Arshad Shaikh; Nazish Shahid; Anum Mughal; Ribak Umah
Journal:  Diagn Pathol       Date:  2013-05-09       Impact factor: 2.644

7.  Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study.

Authors:  Yaqin Chen; Anthony Bekhash; Albert J Kovatich; Jeffrey A Hooke; Jianfang Liu; Leonid Kvecher; J Leigh Fantacone-Campbell; Edith P Mitchell; Hallgeir Rui; Richard J Mural; Craig D Shriver; Hai Hu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

8.  Risk factors for benign breast disease according to histopathological type: comparisons with risk factors for breast cancer.

Authors:  Y Minami; N Ohuchi; Y Taeda; A Fukao; S Hisamichi
Journal:  Jpn J Cancer Res       Date:  1998-02

9.  Family History, Reproductive, and Lifestyle Risk Factors for Fibroadenoma and Breast Cancer.

Authors:  Jingmei Li; Keith Humphreys; Peh Joo Ho; Mikael Eriksson; Eva Darai-Ramqvist; Linda Sofie Lindström; Per Hall; Kamila Czene
Journal:  JNCI Cancer Spectr       Date:  2018-12-10

10.  Risk factors for benign ovarian teratomas.

Authors:  F Parazzini; C La Vecchia; E Negri; S Moroni; A Villa
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.